首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
CeftazidimeAcquired drug resistance: case report
被引:0
|
作者
:
机构
:
来源
:
Reactions Weekly
|
2025年
/ 2042卷
/ 1期
关键词
:
D O I
:
10.1007/s40278-025-74910-8
中图分类号
:
学科分类号
:
摘要
:
引用
收藏
页码:111 / 111
相关论文
共 50 条
[31]
LevofloxacinAcquired drug resistance: case report
Reactions Weekly,
2023,
1964
(1)
: 252
-
252
[32]
LamivudineDevelopment of drug resistance: case report
Reactions Weekly,
2019,
1758
(1)
: 212
-
212
[33]
CrizotinibAcquired drug resistance: case report
Reactions Weekly,
2023,
1958
(1)
: 167
-
167
[34]
MeropenemAcquired drug resistance: case report
Reactions Weekly,
2021,
1839
(1)
: 184
-
184
[35]
PralsetinibAcquired drug resistance : case report
Reactions Weekly,
2024,
2035
(1)
: 426
-
426
[36]
GefitinibAcquired drug resistance: case report
Reactions Weekly,
2020,
1833
(1)
: 185
-
185
[37]
GefitinibAcquired drug resistance: case report
Reactions Weekly,
2021,
1866
(1)
: 187
-
187
[38]
TemozolomideHypermutagenesis and drug resistance: case report
Reactions Weekly,
2021,
1851
(1)
: 341
-
341
[39]
InfliximabDevelopment of drug resistance: case report
Reactions Weekly,
2021,
1847
(1)
: 244
-
244
[40]
BedaquilineEmergence of drug resistance: case report
Reactions Weekly,
2019,
1777
(1)
: 52
-
52
←
1
2
3
4
5
→